Investing.com - Financial Markets Worldwide

HUTCHMED to announce 2025 half-year results on August 7

Published 03/07/2025, 09:34
HUTCHMED to announce 2025 half-year results on August 7
HCM
-8.55%
HCM
-8.03%

HONG KONG/SHANGHAI/FLORHAM PARK - HUTCHMED (China) Limited (Nasdaq/AIM:HCM; HKEX:13) will release its financial results for the first half of 2025 on Thursday, August 7, 2025, the biopharmaceutical company announced in a press release.

The results, covering the six-month period ended June 30, 2025, will be published at 7:00 am Eastern Daylight Time (EDT), which corresponds to 12:00 noon British Summer Time (BST) and 7:00 pm Hong Kong Time (HKT).

Following the results announcement, HUTCHMED management will host two separate webcasts for analysts and investors. The English-language presentation is scheduled for 8:00 am EDT on August 7, while a Chinese (Putonghua) session will take place at 8:30 am HKT on August 8.

Both webcasts will include question-and-answer sessions and will be accessible through the company’s website, according to the statement.

HUTCHMED describes itself as an innovative, commercial-stage biopharmaceutical company focused on discovering, developing, and commercializing targeted therapies and immunotherapies for cancer and immunological diseases. The company currently has three medicines marketed in China, with one of these also approved in multiple international markets including the United States, Europe, and Japan.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.